<DOC>
	<DOCNO>NCT02066259</DOCNO>
	<brief_summary>The OctavaColon test qualitative plasma test indicate people 18 year age suspect colon abnormality . The blood test provide additional information doctor course colon cancer diagnosis normal population high risk population</brief_summary>
	<brief_title>OctavaColon Cancer Blood Tests OctavaGold OctavaSilver - Blood Tests Help Diagnosis Colon Cancer Clinical Study Protocol</brief_title>
	<detailed_description>The clinical objective study develop two antibody-based blood test additional information colon cancer diagnosis - 1 . Highly specific ( OctavaGold ) - provide additional information doctor evaluation normal population . 2 . Highly sensitive ( OctavaSilver ) - provide additional information doctor evaluation high risk population . The study consider successful achieve least one follow set performances - 1 . For OctavaGold - 95 % specificity least 50 % sensitivity . 2 . For OctavaSilver - 95 % sensitivity least 50 % specificity . The biological objective study find best set antigen , combine appropriate algorithm support clinical objective</detailed_description>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<criteria>Subjects 18 year . Subjects schedule colonoscopy surgery Subjects le 18 year age Previous concurrent synchronous cancer previous malignancy colon recover melanoma Autoimmune disorder diagnose subject Hematological malignancy Subjects active chemotherapy treatment chemotherapy past 6 month Steroid treatment past 3 month Subject undergoing immunosuppressive treatment Subject verify melanoma colon cancer Subject verify sarcoma colon cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>colon cancer</keyword>
	<keyword>cancer associate auto antibody</keyword>
	<keyword>colon cancer blood test</keyword>
</DOC>